thiazoles has been researched along with Acute Hepatic Failure in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Carambia, A; Ghallab, A; Heeren, J; Herkel, J; Lohse, AW; Lommetz, C; Reinders, J; Schramm, C; Schuran, FA; Schwinge, D; Steudter, A; Wieschendorf, B; Zuehlke, S | 1 |
Chawla, Y; Majumdar, M; Ratho, R; Singh, MP | 1 |
Drinkard, CR; Graham, DJ; Shatin, D | 1 |
Graham, DJ; Green, L; Nourjah, P; Senior, JR | 1 |
Chandramouli, J; Tolman, KG | 1 |
Shimizu, N | 1 |
Jagannath, S; Rai, R | 1 |
Chaudhry, MU; Simmons, DL | 1 |
Burgess, MJ; Drinkard, CR; Graham, DJ; Shatin, D; Tsong, Y | 1 |
2 review(s) available for thiazoles and Acute Hepatic Failure
Article | Year |
---|---|
Hepatotoxicity of the thiazolidinediones.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Failure, Acute; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2003 |
[Proper usage of thiazolidinediones].
Topics: Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Failure, Acute; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
7 other study(ies) available for thiazoles and Acute Hepatic Failure
Article | Year |
---|---|
Aryl Hydrocarbon Receptor Activity in Hepatocytes Sensitizes to Hyperacute Acetaminophen-Induced Hepatotoxicity in Mice.
Topics: Acetaminophen; Animals; Basic Helix-Loop-Helix Transcription Factors; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Female; Hepatocytes; Humans; Indoles; Liver; Liver Failure, Acute; Male; Mice; Mice, Knockout; Receptors, Aryl Hydrocarbon; Thiazoles | 2021 |
High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E.
Topics: Adult; Biomarkers; Colorimetry; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Hepatitis E; HMGB1 Protein; Humans; Leukocytes, Mononuclear; Liver Failure, Acute; Male; Real-Time Polymerase Chain Reaction; Statistics, Nonparametric; Tetrazolium Salts; Thiazoles | 2013 |
Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.
Topics: Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Chromans; Female; Hospitalization; Humans; Hypoglycemic Agents; Incidence; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
Troglitazone-induced liver failure: a case study.
Topics: Age Distribution; Aged; Chemical and Drug Induced Liver Injury; Chromans; Chronic Disease; Confidence Intervals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug and Narcotic Control; Female; Humans; Liver Failure; Liver Failure, Acute; Liver Function Tests; Male; Middle Aged; Odds Ratio; Probability; Registries; Risk Assessment; Severity of Illness Index; Sex Distribution; Survival Rate; Thiazoles; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2003 |
Rapid-onset subfulminant liver failure associated with troglitazone.
Topics: Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Failure, Acute; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2000 |
Case of the month. Hepatic and renal failure in a patient taking troglitazone and metformin.
Topics: Acute Kidney Injury; Chromans; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Liver Failure, Acute; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Liver enzyme monitoring in patients treated with troglitazone.
Topics: Chromans; Drug Labeling; Humans; Hypoglycemic Agents; Liver; Liver Failure, Acute; Liver Function Tests; Risk Management; Thiazoles; Thiazolidinediones; Transaminases; Troglitazone; United States; United States Food and Drug Administration | 2001 |